Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 14;20(29):8942-7.
doi: 10.1002/chem.201403094. Epub 2014 Jun 24.

Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate

Affiliations

Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate

Grégory Thiabaud et al. Chemistry. .

Abstract

In an effort to increase the stability and control the platinum reactivity of platinum-texaphyrin conjugates, two Pt(IV) conjugates were designed, synthesized, and studied for their ability to form DNA adducts. They were also tested for their anti-proliferative effects using wild-type and platinum-resistant human ovarian cancer cell lines (A2780 and 2780CP, respectively). In comparison to an analogous first-generation Pt(II) chimera, one of the new conjugates provided increased stability in aqueous environments. Using a combination of (1) H NMR spectroscopy and FAAS (flameless atomic-absorption spectrometry), it was found that the Pt(IV) center within this conjugate undergoes photoinduced reduction to Pt(II) upon exposure to glass-filtered daylight, resulting in an entity that binds DNA in a controlled manner. Under conditions in which the Pt(IV) complex is reduced to the corresponding Pt(II) species, these new conjugates demonstrated potent anti-proliferative activity in both test ovarian cancer cell lines.

Keywords: conjugates; drug design; photo-activation; platinum; texaphyrin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Partial RP-HPLC chromatograms (top) and 1H-NMR spectra (bottom, D2O, pH = 7, 300 K, 400 MHz) of complex 3 recorded in the presence of 5′-GMP (2 equiv.) before (A) and after being exposed to laboratory light for 2 days (B); (C) cisplatin incubated in presence of 5′-GMP (2 equiv.) for 10 h at 37°C; circle = free 5′-GMP; triangle = PtII-coordinated 5′-GMP; black square = PtIV-coordinated succinate anion; square = free succinate dianion.
Figure 2
Figure 2
(A) Schematic representation of the photo-activation of 4 followed by formation of a DNA-Pt adduct. Note: The star represents the texaphyrin moiety; (B) stability (RP-HPLC analysis) of 4 in PBS solution in the dark (black circles) or exposed to laboratory light (black squares), The designation 1 indicates the hydrolysis phase (absence of light), while the 2 indicates the phase corresponding to light exposure; (C) quantification by FAAS (Pt) and by nanodrop (DNA) of the number of Pt-DNA adducts formed after reaction of 4 with DNA in the dark (black circles) or exposed to natural light (black squares).
Scheme 1
Scheme 1
Structures of compounds considered in this study.
Scheme 2
Scheme 2
Synthesis of the platinum(IV)-texaphyrin conjugates 4 and 5. R1 = (OCH2CH2)3OCH3. Conditions: i = 4,4′-dimethoxytriphenylmethylchloride (DMT-Cl), diisopropylethylamine (DIPEA) in dichloromethane, 30%; ii = triphenylphosphine, phthalimide, diisopropylazocaboxylate in dichloromethane, methylamine in methanol/acetonitrile, 25%; iii = N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC•HCl), N-hydroxysuccinimide (NHS) and 3 in water. Yields were 40% (4) and 20% (5).

Similar articles

Cited by

References

    1. Wexselblatt E, Gibson D. J Inorg Biochem. 2012;117:220–229. - PubMed
    2. Wexselblatt E, Yavin E, Gibson D. Inorg Chim Acta. 2012;393:75–83.
    1. Kelland L. Nat Rev cancer. 2007;7:573–584. - PubMed
    2. Rabik CA, Dolan ME. Cancer Treat Rev. 2007;33:9–23. - PMC - PubMed
    1. Miller RA, Woodburn K, Fan Q, Renschler M, Sessler JL, Koutcher JA. Int J Radiat Oncol Biol Phys. 1999;45:981–989. - PubMed
    2. Magda D, Gerasimchuk N, Lecane P, Miller RA, Biaglow JE, Sessler JL. Chem Commun. 2002:2730–2731. - PubMed
    1. Arambula JF, Sessler JL, Siddik ZH. Bioorg Med Chem Lett. 2011;21:1701–1705. - PMC - PubMed
    2. Arambula JF, Sessler JL, Siddik ZH. Med Chem Commun. 2012;3:1275–1281. - PMC - PubMed
    1. Hall MD, Hambley TW. Coord Chem Rev. 2002;232:49–67.

Publication types

MeSH terms